(Q33967265)

30 July 2017

1 reference

title

Serotonin syndrome and other serotonergic disorders (English)

1 reference

30 July 2017

1 reference

Rasih Atilla Ener

1

1 reference

30 July 2017

Sharon B Meglathery

series ordinal

2

1 reference

30 July 2017

William A Van Decker

series ordinal

3

1 reference

30 July 2017

Rollin M Gallagher

series ordinal

4

1 reference

30 July 2017

publication date

1 March 2003

1 reference

30 July 2017

1 reference

30 July 2017

volume

4

1 reference

30 July 2017

issue

1

1 reference

30 July 2017

page(s)

63-74

1 reference

Motor effects of serotonin in the central nervous system

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4637.2003.03005.X

Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4637.2003.03005.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4637.2003.03005.X

The serotonin syndrome and its treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4637.2003.03005.X

Brain stem and spinal cord mediation of a serotonergic behavioral syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4637.2003.03005.X

5-HT and motor control: a hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4637.2003.03005.X

A 5-HT2 receptor mediates serotonin-induced electrolyte transport in rat left colon

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4637.2003.03005.X

Combination monoamine oxidase inhibitor/tricyclic antidepressants interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4637.2003.03005.X

21 January 2018

The serotonin syndrome

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4637.2003.03005.X

Sumatriptan contraindications and the serotonin syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4637.2003.03005.X

The serotonin syndrome associated with paroxetine, an over-the-counter cold remedy, and vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4637.2003.03005.X

Pathophysiology and management of the serotonin syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4637.2003.03005.X

Selective serotonin-reuptake inhibitor-induced movement disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4637.2003.03005.X

SSRI-induced extrapyramidal side-effects and akathisia: implications for treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4637.2003.03005.X

Distribution of serotonin-immunoreactivity in the central nervous system of the rat-cell bodies and terminals

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4637.2003.03005.X

Extrapyramidal side effects and increased serum prolactin following fluoxetine, a new antidepressant

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4637.2003.03005.X

Selective serotonin reuptake inhibitor-induced serotonin syndrome: review

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4637.2003.03005.X

Comparative anxiogenic, neuroendocrine, and other physiologic effects of m-chlorophenylpiperazine given intravenously or orally to healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4637.2003.03005.X

Debrisoquine hydroxylation in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4637.2003.03005.X

Effect of selective serotonin reuptake inhibitors on platelets in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4637.2003.03005.X

Methadone reincarnated: novel clinical applications with related concerns

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4637.2003.03005.X

Genomic medicine--a primer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4637.2003.03005.X

Non-functional CYP2D6 alleles and risk for neuroleptic-induced movement disorders in schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4637.2003.03005.X

10.1046/J.1526-4637.2003.03005.X

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference